Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 8/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.41 |
| ▸ | RELA | Q04206 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31315013 | 1.00 | RAB9A (0.41) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL3735051 | 0.83 | CSNK2A1 (0.44) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL27774516 | 0.83 | MAPT (0.44) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL12121788 | 0.81 | NPC1 (0.41) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL1329346 | 0.81 | CYP2A6 (0.42) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A | |
| SCHEMBL211284 | 0.81 | CSNK2A1 (0.55) | RAB9ASMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL29775265 | 0.81 | CSNK2A1 (0.55) | RAB9ASMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL302204 | 0.80 | CSNK2A1 (0.48) | RAB9ASMN1; SMN2MAPTKMT2AMEN1 | |
| Benzoyl Chloride SCHEMBL28327933 | 0.79 | POLB (0.46) | RAB9ASMN1; SMN2MAPTKMT2AMEN1 | |
| SCHEMBL305165 | 0.79 | ERN1 (0.46) | RAB9ASMN1; SMN2MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345812-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-26 | — | — | US | disclosed |
| CN-112321648-B | P-containing organic electrophosphorescent material and application thereof | 北京燕化集联光电技术有限公司 | 2022-12-02 | — | — | CN | disclosed |
| CN-112175016-B | Organic electrophosphorescent luminescent material and application thereof | 北京燕化集联光电技术有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-112321647-B | Iridium complex containing benzimidazole structure and application thereof | 北京燕化集联光电技术有限公司 | 2022-08-16 | — | — | CN | disclosed |
| CN-112341499-B | Sulfur-containing organic electrophosphorescent luminescent material and application thereof | 北京燕化集联光电技术有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-112209973-B | Oxygen-containing organic electrophosphorescent material and application thereof | 北京燕化集联光电技术有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-112175017-B | Organic electrophosphorescent material and application thereof | 北京燕化集联光电技术有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-112341499-A | Sulfur-containing organic electrophosphorescent luminescent material and application thereof | 北京燕化集联光电技术有限公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-112321648-A | P-containing organic electrophosphorescent material and application thereof | 北京燕化集联光电技术有限公司 | 2021-02-05 | — | — | CN | disclosed |
| CN-112321647-A | Iridium complex containing benzimidazole structure and application thereof | 北京燕化集联光电技术有限公司 | 2021-02-05 | — | — | CN | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| US-20150318498-A1 | Metal Complexes | MERCK PATENT GMBH (DE) | 2015-11-05 | — | — | US | disclosed |
| CN-104080783-A | Pyrrole compounds | YAKULT HONSHA KK | 2014-10-01 | — | — | CN | disclosed |
| WO-2014094962-A2 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2014-06-26 | — | — | WO | disclosed |
| EP-1289993-A1 | CASPASE INHIBITORS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001094351-A1 | CASPASE INHIBITORS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2001-12-13 | — | — | WO | disclosed |
| US-5237099-A | Insecticidal substituted and unsubstituted benzoic acid 1-alkyl, 2-alkyl and 2-cycloalkylhydrazides | AMERICAN CYANAMID COMPANY (US) | 1993-08-17 | — | — | US | disclosed |
| US-5117057-A | Insecticidal N' substituted-N-N'-disubstituted-hydrazines | ROHM AND HAAS COMPANY (US) | 1992-05-26 | — | — | US | disclosed |
| US-4814349-A | Insecticidal substituted and unsubstituted benzoic acid 1-alkyl, 2 alkyl and 2-cycloalkylhydrazides | AMERICAN CYANAMID COMPANY (US) | 1989-03-21 | — | — | US | disclosed |
| EP-0228564-A2 | Novel insecticidal diacylhydrazine compounds | AMERICAN CYANAMID COMPANY (US) | 1987-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230345812-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OPRD1, OCIAD2 | RAB9A 799/4885SMN1; SMN2 3117/4885MAPT 4205/4885 |
| US-20150318498-A1 | Metal Complexes | SOD1, AP1M1, AP3M1 | RAB9A 2201/4885SMN1; SMN2 3736/4885MAPT 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.